C2N Diagnostics LLC, a St. Louis-based biotechnology firm that developed blood-based tests for Alzheimer's and other neurological diseases, has received a grant from The Michael J. Fox Foundation for ...
The firm will use its blood-based tests to explore connections between Alzheimer's disease and neuronal α-synuclein conditions including Parkinson's disease.